
Polymers for Oral Drug Delivery Technologies
- 1st Edition - September 30, 2024
- Editor: Anilkumar Parambath
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 3 7 7 4 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 3 7 7 5 - 4
Polymers for Oral Drug Delivery Technologies covers the fundamentals of oral drug delivery and various aspects of polymer technology in oral drug delivery, from classi… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quotePolymers play an important role to achieve the targeted release profile consistently of an API in vivo by various functionalities like drug protection from gastric juice, fast release and supersaturation or release within a targeted area of the GI tract.
- Provides a comprehensive update on the state of polymer technology for oral drug delivery, bringing the reader up-to-speed via a single reference
- Covers a range of polymer technology types, including capsule forming polymers, matrix formers, functional polymer coatings, and more
- Contains contributions from global experts spanning academia and industry, offering an interdisciplinary and translational approach to polymers for oral drug delivery
- Cover image
- Title page
- Table of Contents
- Copyright
- List of contributors
- Preface
- Section I: Fundamentals of oral drug delivery
- 1. Gastrointestinal tract environment and its implications on oral drug delivery
- Abstract
- 1.1 Introduction
- 1.2 Overview of the gastrointestinal tract
- 1.3 Key regions of the gastrointestinal tract involved in oral drug delivery and absorption: physiological differences and their implication on absorption
- 1.4 Other barriers to the absorption of drugs
- 1.5 Factors affecting polymer-based oral drug delivery and formulation strategies for site-specific drug delivery to gastrointestinal tract
- 1.6 Future prospective
- 1.7 Conclusion
- References
- 2. Gastrointestinal tract motility and transport
- Abstract
- 2.1 Introduction
- 2.2 Gastrointestinal motility and its regulation for motility
- 2.3 Microbiota, gastrointestinal transit time, and diet correlation
- 2.4 Role of the gut microbiota and its metabolites as a key regulator of gut motility
- 2.5 Conclusion
- References
- 3. Drug absorption and presystemic metabolism and pharmacokinetic modeling
- Abstract
- 3.1 Introduction
- 3.2 Drug absorption
- 3.3 Passive diffusion
- 3.4 Carrier-mediated membrane transporters
- 3.5 In vitro ex-vivo and in vivo methods for assessing drug absorption and permeability
- 3.6 Presystemic metabolism
- 3.7 Pharmacokinetic modeling
- 3.8 Basic concepts of pharmacokinetics
- 3.9 Pharmacokinetic analysis using model approach
- 3.10 Future directions and challenges
- References
- 4. In vitro dissolution and predictive release testing
- Abstract
- 4.1 Introduction
- 4.2 Compendial dissolution methods
- 4.3 Limitations of compendial dissolution methods
- 4.4 Noncompendial dissolution methods and modifications
- 4.5 Future outlook
- References
- 5. Principle characteristics and specification of pharmaceutical polymers
- Abstract
- 5.1 Introduction
- 5.2 Polymers with smart properties
- 5.3 Advantages of polymer
- 5.4 Characteristics of ideal polymer for pharmaceutical applications
- 5.5 Physicochemical properties of polymers and factors affecting oral drug delivery abilities
- 5.6 Degree of polymerization and molecular mass
- 5.7 Hydrophobicity
- 5.8 Polymer crystallinity
- 5.9 Melting point and glass transition temperature
- 5.10 Surface charge
- 5.11 Coating material
- 5.12 Classification of polymers
- 5.13 Classification based on origin
- 5.14 Natural polymers
- 5.15 Synthetic polymers
- 5.16 Classification based on structure
- 5.17 Linear polymers
- 5.18 Branching polymers
- 5.19 Cross-linking polymers
- 5.20 Biopolymers
- 5.21 Classification based on crystallinity
- 5.22 Crystalline
- 5.23 Semicrystalline
- 5.24 Amorphous
- 5.25 Classification based on intermolecular forces
- 5.26 Thermoset
- 5.27 Thermoplasts
- 5.28 Fibers
- 5.29 Elastomer
- 5.30 Classification of smart polymers
- 5.31 Temperature sensitive polymers
- 5.32 pH-sensitive polymers
- 5.33 Glucose-sensitive polymers
- 5.34 Photo-sensitive polymers
- 5.35 Mucoadhesive polymers
- 5.36 Bioadhesive polymers
- 5.37 Methods of drugs release from polymers
- 5.38 Release by diffusion method
- 5.39 Reservoir-type diffusion mechanism
- 5.40 Matrix-type diffusion mechanism
- 5.41 Release by degradation method
- 5.42 Chemical degradation method
- 5.43 Hydrolytic degradation method
- 5.44 Enzymatic degradation method
- 5.45 Release by swelling method
- 5.46 Factors contributing to polymer degradation
- 5.47 Pharmaceutical applications of polymers
- 5.48 Targeted polymeric drug delivery
- 5.49 Applications of polymers in tablet formulation
- 5.50 Applications of polymers in capsules
- 5.51 Applications of polymers disperse systems
- 5.52 Applications of polymers for mucoadhesive delivery
- 5.53 Applications of polymers for ophthalmic delivery
- 5.54 Applications of polymers for cardiac implants
- 5.55 Applications of polymers for cancer treatment
- 5.56 Applications of polymers in disease diagnosis
- 5.57 Future prospects
- 5.58 Conclusion
- Funding
- Acknowledgments
- References
- 6. Regulatory aspects of polymers used and new polymers for oral medication of gastroretentive dosage forms
- Abstract
- 6.1 Introduction
- 6.2 Regulatory framework for polymers in oral medication
- 6.3 Polymer toxicity and its safety assessment for oral medication
- 6.4 Current challenges and future directions
- 6.5 Conclusion
- References
- Section II: Role polymer technology in oral drug delivery
- 7. Classes/types of polymers used in oral delivery (natural, semisynthetic, synthetic), their chemical structure and general functionalities
- Abstract
- 7.1 Introduction to polymers in oral delivery
- 7.2 Natural polymers in oral delivery
- 7.3 Semisynthetic polymers in oral delivery
- 7.4 Synthetic polymers in oral delivery
- 7.5 Comparative analysis and selection criteria for polymers in oral
- 7.6 Conclusion and future perspectives
- References
- 8. Role of polymers in tableting
- Abstract
- 8.1 Introduction
- 8.2 Basics of tableting powder compaction, and deformation physics
- 8.3 Basic tablet composition
- 8.4 Mechanical, powder, and solid-state behavior of polymers relevant to tableting
- 8.5 Tablet characterization and material sciences
- 8.6 Future perspective
- References
- 9. Capsule-forming polymers
- Abstract
- 9.1 Introduction
- 9.2 Polymers for capsule formation
- 9.3 Requirements of capsule formulation
- 9.4 Manufacturing technologies of capsule
- 9.5 Capsule-filling technologies
- 9.6 Packaging and storage of capsules
- 9.7 Quality control tests for capsules
- 9.8 Benefits of polymeric capsules
- 9.9 Capsule technology trends
- 9.10 Conclusion
- References
- 10. Dry and wet granulation
- Abstract
- 10.1 Introduction
- 10.2 Purpose of granulation
- 10.3 Granulation techniques
- 10.4 Mechanism of granulation
- 10.5 Selection of process and equipment
- 10.6 Selection of excipients
- 10.7 Use of artificial intelligence in granulation processes
- References
- 11. Matrix formers
- Abstract
- 11.1 Introduction
- 11.2 Uses of polymer in pharmaceutical delivery
- 11.3 Classification of polymers
- 11.4 Oral drug delivery system
- 11.5 Matrix system
- 11.6 Designing of matrix systems
- 11.7 Discussion on the formation of matrix by polymer in various oral delivery systems
- 11.8 Scope
- 11.9 Challenges
- 11.10 Conclusion
- References
- 12. Functional polymeric coatings for immediate release dosage forms
- Abstract
- 12.1 Introduction
- 12.2 Need for functional polymeric coatings
- 12.3 Pharmaceutical coating: the utilization of polymers
- 12.4 Other additives
- 12.5 Recent advances in functional polymeric coatings
- 12.6 Summary and conclusion
- References
- 13. Polymeric carriers for amorphous solid dispersion
- Abstract
- 13.1 Introduction
- 13.2 Classification of polymers
- 13.3 Considerations during the selection of polymers for ASD
- 13.4 Polymers and preparation methods
- 13.5 Mechanism of stabilization
- 13.6 Mechanism of solubility and dissolution improvement
- 13.7 Manufacturing and scaling-up issues of polymeric ASDs
- 13.8 Regulatory considerations on polymers as excipients
- 13.9 Concluding remark
- References
- 14. Micro/nanoparticles
- Abstract
- 14.1 Introduction
- 14.2 Physiological barriers to oral drug delivery
- 14.3 Fundamental of micro/nanoparticles
- 14.4 Drug loading factors in microparticles/nanoparticles
- 14.5 Role of micro/nanoparticles in overcoming barriers
- 14.6 Applications of micro/nanoparticles in oral drug delivery
- 14.7 Safety and toxicity considerations
- 14.8 Clinical trials and commercial products
- 14.9 Regulatory considerations
- 14.10 Conclusion
- References
- 15. Taste masking polymers
- Abstract
- 15.1 Introduction
- 15.2 Water soluble polymers
- 15.3 Water insoluble polymers
- 15.4 Need and concept of taste masking
- 15.5 Taste masking technologies
- 15.6 Advanced approaches for taste masking
- 15.7 Future prospective
- 15.8 Conclusion
- Acknowledgments
- References
- 16. Polymers in orally disintegrating tablets and orally dissolving films
- Abstract
- 16.1 Introduction
- 16.2 Significance of polymers in formulating ODFs and ODTs
- 16.3 Advantages of ODTs and ODFs over conventional oral dosage forms
- 16.4 Polymers in orally disintegrating tablets
- 16.5 Selection criteria of superdisintegrant
- 16.6 Manufacturing techniques for ODTs
- 16.7 Commonly used manufacturing techniques for ODTs
- 16.8 Direct compression method
- 16.9 Freeze drying method
- 16.10 Mass extrusion method
- 16.11 Spray-dried method
- 16.12 Polymers in orally dissolving films
- 16.13 Polymers in ODF formulations
- 16.14 Manufacturing processes
- 16.15 Solvent‑casting method
- 16.16 Hot‑melt extrusion
- 16.17 Solid dispersion extrusion
- 16.18 Rolling method
- 16.19 Conclusion
- Competing interests
- Funding
- Acknowledgment
- Conflict of interest
- References
- 17. Additive manufacturing (3d printing)
- Abstract
- 17.1 Introduction
- 17.2 3D printing procedure
- 17.3 Types of 3D printing technology
- 17.4 Polymers used in 3DP
- 17.5 Miscellaneous
- 17.6 Future perspectives and challenges
- 17.7 Conclusions
- References
- 18. Mucoadhesive forms
- Abstract
- Abbreviations
- 18.1 Introduction
- 18.2 Mucoadhesive polymers
- 18.3 Oral mucoadhesive dosage forms
- 18.4 Evaluation techniques for mucoadhesive dosage forms
- 18.5 Applications of mucoadhesive dosage forms
- 18.6 Patents and marketed products
- 18.7 Regulatory consideration
- 18.8 Current status and future perspective
- 18.9 Conclusion
- References
- 19. Gastroretentive dosage forms
- Abstract
- 19.1 Introduction
- 19.2 Physicochemical properties of gastroretentive drug delivery systems
- 19.3 Concept of gastroretentive dosage forms
- 19.4 Classification of gastroretentive drug delivery systems
- 19.5 Critical factors affecting gastroretentive drug delivery systems efficacy
- 19.6 Application of gastroretentive drug delivery systems
- 19.7 Emerging technologies of gastroretentive drug delivery systems
- 19.8 Conclusion
- References
- 20. Polymer blends and additives
- Abstract
- Abbreviations
- 20.1 Introduction
- 20.2 Polymer blends and their characteristics
- 20.3 Classification of polymer blends
- 20.4 Molecular level blends
- 20.5 Polymer blend interactions
- 20.6 Methods of polymer blending
- 20.7 Solution coating
- 20.8 Application of polymer blends in oral drug delivery
- 20.9 Polymer additives
- 20.10 Properties imparted by polymer additives
- 20.11 Conclusion
- Acknowledgments
- Conflict of interest
- References
- Index
- No. of pages: 854
- Language: English
- Edition: 1
- Published: September 30, 2024
- Imprint: Woodhead Publishing
- Paperback ISBN: 9780443137747
- eBook ISBN: 9780443137754
AP
Anilkumar Parambath
Dr Anilkumar Parambath is Senior R&D Manager of YTY Group, Indorama Corp., Perak, Malaysia. Prior to this, he was R&D Manager, Science & Technology at Unilever (2021-2024); Senior Manager and Head of Capsules Product R&D, ACG Capsules, Mumbai, India (2018-2021) and Principal Investigator for Performance and Specialty Materials at Syngene International Ltd, Bangalore India (2017-2018), where he worked on developing various elastomers, silicones, acrylics and other polymers for biomedical applications. He completed his PhD in Chemistry (Polymer Science) at the University of Kerala, India, and spent 7 years conducting post-doctoral research at Clemson University, USA, French atomic Energy Commission (CEA), France, and the University of British Columbia, Canada. HIs expertise is in polymer science, materials science, green chemistry, nanotechnology, nanomedicine, and biomaterials science. Dr. Parambath has edited three books on polymer biomaterials in drug delivery applications, including two with Elsevier, and has published many books chapters and journal articles. He has two patents to his name. In 2024, he was recognized by the American Chemical Society (ACS) as a Sustainability Star.